ClinicalTrials.Veeva

Menu

A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation

N

Nova Scotia Health Authority (NSHA)

Status

Withdrawn

Conditions

Airway Management

Study type

Observational

Funder types

Other

Identifiers

NCT01209559
CDHA-RS/2011-156

Details and patient eligibility

About

The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA

Exclusion criteria

  • history of acid reflux,
  • a BMI ≥ 40kg.m-2,
  • require endotracheal intubation,
  • have predictors of difficult intubation,
  • not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,
  • cannot consent to the study

Trial design

0 participants in 2 patient groups

air-Q Intubating Laryngeal Airway
LMA FastrachTM or ILMA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems